TNFRSF11B and osteoporosis: Since OPG was first cloned as a “osteoprotective” factor in 1997, it has long been thought that the OPG level in the bone tissue is an important determinant of bone mass, and that the serum OPG level may also be associated with bone pathologies such as osteoporosis and rheumatoid arthritis.